• A 44-year-old man with recurrent ST-segment elevation: a case report of two presentations of Granulomatosis with Polyangiitis
• A Case of Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab: A Case Report
• A multidisciplinary approach of a patient with pheochromocytoma presenting as recurrent acute fulminant myocarditis: A rare case report and comprehensive review of literature
• Acacetin alleviates autoimmune myocarditis by regulating CD4+ T cell mitochondrial respiration
• Activation of ETAR and ETBR in myocardial tissue characterizes heart failure induced by experimental autoimmune myocarditis
• Acute lymphocytic myocarditis characterized by cardiogenic shock and conduction system abnormalities in patients with Hashimoto's thyroiditis: a case report and review of literature
• Acute myocarditis: an overview of pathogenesis, diagnosis and management
• Adjuvants in COVID-19 vaccines: innocent bystanders or culpable abettors for stirring up COVID-heart syndrome
• Advances in research on molecular markers in immune checkpoint inhibitor-associated myocarditis
• An 85-Year-Old Man with Fever, Dyspnea, and Dry Cough Diagnosed with Idiopathic Hypereosinophilic Syndrome, Successfully Treated with High-Dose Corticosteroids
• Anti-CTLA-4 m2a Antibody Exacerbates Cardiac Injury in Experimental Autoimmune Myocarditis Mice By Promoting Ccl5-Neutrophil Infiltration
• Autoimmune Myocarditis, Old Dogs and New Tricks
• Baicalein alleviates cardiomyocyte death in EAM mice by inhibiting the JAK-STAT1/4 signalling pathway
• Biomarkers in Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Updated Review of the Literature
• Cardiac arrest in seronegative idiopathic inflammatory myopathy: a case report
• Cardiac involvement in systemic lupus erythematosus: Interest of 2D global longitudinal strain
• Cardiovascular Disease: Inflammatory and Infectious Heart Conditions
• Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor
• Case report: Systemic lupus erythematosus combined with myocardial hypertrophy
• CD4(+)T(EM) cells drive the progression from acute myocarditis to dilated cardiomyopathy in CVB3-induced BALB/c mice
• CD4⁺T_EM cells drive the progression from acute myocarditis to dilated cardiomyopathy in CVB3-induced BALB/c mice
• Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade-a worldwide perspective
• COVID-19 mRNA Vaccination-Induced Myopericarditis in an Otherwise Healthy Young Male: An Evidence-Based Approach to Differentiating From Perimyocarditis
• COVID-related constrictive pericarditis requiring pericardiectomy: a case report
• Cryptic late-onset myocarditis after coronavirus vaccination
• Diagnosis and treatment of myocarditis and inflammatory cardiomyopathy. Consensus document of the SEC-Working Group on Myocarditis
• Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study
• Editorial: Cardiovascular involvement in autoimmune diseases, volume II
• Effect and mechanism of T lymphocytes on human induced pluripotent stem cell-derived cardiomyocytes via Proteomics
• Empagliflozin alleviates the development of autoimmune myocarditis via inhibiting NF-kappaB-dependent cardiomyocyte pyroptosis
• Empagliflozin alleviates the development of autoimmune myocarditis via inhibiting NF-κB-dependent cardiomyocyte pyroptosis
• Empagliflozin attenuates inflammation levels in autoimmune myocarditis through the STAT3 pathway and macrophage phenotype transformation
• Endosomal Toll-Like Receptors intermediate negative impacts of viral diseases, autoimmune diseases, and inflammatory immune responses on the cardiovascular system
• Extracorporeal membrane oxygenation (ECMO) during aplasia: A bridge towards myopericarditis recovery after autologous hematopoietic stem cell transplant for systemic sclerosis and recent Coronarovirus disease (COVID-19) vaccination
• Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease
• Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease
• Fulminant myocarditis in a patient with a history of autoimmune hepatitis
• High-throughput discovery of MHC class I- and II-restricted T cell epitopes using synthetic cellular circuits
• IFITM3 mediates inflammation induced myocardial injury through JAK2/STAT3 signaling pathway
• Imaging in Rheumatic Immune-related Adverse Events
• Immune checkpoint inhibitor myocarditis in thymic epithelial tumors: a case report and literature review
• Immune-Related Adverse Events Associated with Atezolizumab: Insights from Real-World Pharmacovigilance Data
• Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature
• Immunomodulating and Immunosuppressive Therapy for Virus-Negative Immune-Mediated Myocarditis
• Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: Rationale & design of the ARCHER trial
• Innate and adaptive immunity in acute myocarditis
• Investigation into Cardiac Myhc-alpha 334-352-Specific TCR Transgenic Mice Reveals a Role for Cytotoxic CD4 T Cells in the Development of Cardiac Autoimmunity
• Investigation into Cardiac Myhc-α 334-352-Specific TCR Transgenic Mice Reveals a Role for Cytotoxic CD4 T Cells in the Development of Cardiac Autoimmunity
• Ivabradine Alleviates Experimental Autoimmune Myocarditis-Mediated Myocardial Injury
• Ivermectin ameliorates acute myocarditis via the inhibition of importin-mediated nuclear translocation of NF-kappaB/p65
• Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab
• LncRNA MAAMT facilitates macrophage recruitment and proinflammatory activation and exacerbates autoimmune myocarditis through the SRSF1/NF-kappaB axis
• Long term false positive hsTnI on Alinity I probably caused by macrotroponin complex: Case report
• Lupeol alleviates autoimmune myocarditis by suppressing macrophage pyroptosis and polarization via PPARalpha/LACC1/NF-kappaB signaling pathway
• Lupeol alleviates autoimmune myocarditis by suppressing macrophage pyroptosis and polarization via PPARα/LACC1/NF-κB signaling pathway
• Lupus-Induced Accelerated Heart Failure in a Young African American Female: Cardiovascular and Systemic Complications of Noncompliance to Maintenance Therapy and the Social Determinants of Cardiovascular Disease
• Macrophage membrane-modified targeted phase-change nanoparticles for multimodal imaging of experimental autoimmune myocarditis
• Mitochondrial extracellular vesicles, autoimmunity and myocarditis
• MLN4924 alleviates autoimmune myocarditis by promoting Act1 degradation and blocking Act1-mediated mRNA stability
• Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors
• Molecular mimic between cardiovascular diseases and microorganism antigens
• Mortality associated with myocardial damage by troponin I in patients with COVID 19
• Myocarditis and Pericarditis
• Myosin Heavy Chain 7 (MYH7) Variant Associated Cardiovascular Disease: An Unusual Case of Heart Failure in a Young Male
• Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study
• Novel uses of complement inhibitors in myasthenia gravis-Two case reports
• Pentraxin 3 in Myocarditis: Proof-of-Principle Assessment as a Diagnostic and Prognostic Biomarker
• Perioperative cardiac risks in myasthenia gravis
• Peripheral nervous system immune-related adverse events due to checkpoint inhibition
• Peripheral Neuropathy and Muscle Disorders as Immune-Related Adverse Events
• Potential clinical implications of molecular mimicry-induced autoimmunity
• Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy
• Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity
• Profibrotic VEGFR3-Dependent Lymphatic Vessel Growth in Autoimmune Valvular Carditis
• Protective effect of low-intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4(+) T-cell differentiation
• Protective effect of low-intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4⁺ T-cell differentiation
• Proteomic mapping identifies serum marker signatures associated with MIS-C specific hyperinflammation and cardiovascular manifestation
• Radiotracers for Imaging of Inflammatory Biomarkers TSPO and COX-2 in the Brain and in the Periphery
• Rare pediatric case of two episodes of fulminant myocarditis and cardiac dysfunction after viral infection
• Rho kinase inhibitor Y-27632 downregulates IL-1beta expression in mice with experimental autoimmune myocarditis
• RhoA/ROCK Pathway Is Upregulated in Experimental Autoimmune Myocarditis and Is Inhibited by Simvastatin at the Stage of Myosin Light Chain Phosphorylation
• Role of CCRL2 in the Pathogenesis of Experimental Autoimmune Myocarditis via P21-Activated Kinase 1/NOD-Like Receptor Protein 3 Pathway
• Sacubitril/Valsartan inhibits M1 type macrophages polarization in acute myocarditis by targeting C-type natriuretic peptide
• SARS-CoV-2-induced non-bacterial endomyocarditis with the development of acquired heart defects
• Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies
• Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report
• Severe Mitral Valve Regurgitation Secondary to Fulminant Myocarditis in the Setting of a Lupus Flare
• Sex differences in mitochondrial gene expression during viral myocarditis
• Subcutaneous anakinra in the management of refractory MIS-C in France
• Systematic Aetiological Assessment of Myocarditis: A Prospective Cohort Study
• T-Cell Receptor Sequences Identify Combined Coxsackievirus-<em>Streptococci</em> Infections as Triggers for Autoimmune Myocarditis and Coxsackievirus-<em>Clostridia</em> Infections for Type 1 Diabetes
• T-Cell Receptor Sequences Identify Combined Coxsackievirus-Streptococci Infections as Triggers for Autoimmune Myocarditis and Coxsackievirus-Clostridia Infections for Type 1 Diabetes
• TGF-beta Signalling Regulates Cytokine Production in Inflammatory Cardiac Macrophages during Experimental Autoimmune Myocarditis
• The Emerging Field of Cardioimmunology: Past, Present and Foreseeable Future
• The role of comprehensive stress cardiac MRI in autoimmune rheumatic disease: A review
• The Role of the Immune System in Pathobiology and Therapy of Myocarditis: A Review
• The Significance of Parametric Mapping in Advanced Cardiac Imaging
• Uneventful COVID-19 Infection and Vaccination in a Cohort of Patients with Prior Myocarditis
• Updates in the pathogenesis and management of immune-related enterocolitis, hepatitis and cardiovascular toxicities
• Vascular adhesion protein-1-targeted PET imaging in autoimmune myocarditis